Clinical outcomes of patients with HER2 gene-amplified metastatic breast cancer treated with first line herceptin [trastuzumab] in combination with a taxane: A phase IV, prospective, community based study
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Taxanes; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Genentech
- 28 Feb 2018 Status changed from active, no longer recruiting to completed.
- 27 Jan 2006 New trial record.